Back-to-Back Upper Circuit & Multubagger 100% Returns in 30-Days: This Candy Making Company Secures Manufacturing Agreements Worth Rs 45 Crore; Reports 141% Revenue Growth in Q1FY26
DSIJ Intelligence-2 / 01 Sep 2025/ Categories: Mindshare, Trending

The deal, valued at Rs 15 crore, will involve Sampre handling manufacturing, supply, quality assurance, and packaging under brand specifications and trademarks.
Sampre Nutritions Limited (BSE: 530617), a Small-Cap confectionery and nutraceutical manufacturer, has announced two significant manufacturing agreements that are expected to strengthen its revenue base and expand operations.
On August 16, 2025, the company entered into a contract with Tolaram Wellness Ltd., Nigeria. Under the agreement, Sampre will manufacture and supply nutraceutical and food products according to agreed specifications and quality standards. The deal is expected to generate Rs 10 crore annually, translating into approximately Rs 30 crore over three years. Payment terms include 50 per cent advance and the remaining on dispatch, while transportation will be borne by Tolaram Wellness. The contract is not a related-party transaction, and Tolaram Wellness does not hold shares in Sampre Nutritions.
Additionally, on August 19, 2025, the company signed another three-year manufacturing agreement with Rama Exports for nutraceutical and food products. The deal, valued at Rs 15 crore, will involve Sampre handling manufacturing, supply, quality assurance, and packaging under brand specifications and trademarks.
DSIJ’s 'Tiny Treasure' service recommends researched small-cap stocks with Inherent Growth Potential. If this interests you, download the service details here.
For Q1FY26, Sampre Nutritions reported strong Quarterly Results with revenue from operations of Rs 10.87 crore, a 141 per cent year-on-year growth compared to Rs 4.51 crore in Q1FY25. Net profit stood at Rs 70.76 lakh, reflecting a 615 per cent increase from Rs 9.89 lakh a year earlier. Earnings Per Share (EPS) rose to Rs 0.34 from Rs 0.11 in the same quarter last year.
The company has also announced plans for fundraising initiatives through preferential issue, qualified institutional placement (QIP), and public or private offerings. A board meeting will be scheduled to seek shareholder approval for this capital raise, which aims to strengthen financials and support expansion.
Sampre Nutritions has also been recognised under the India 5000 Best MSME Awards 2024 for excellence in quality, customer satisfaction, and societal impact. Incorporated in 1991 and headquartered in Medchal, Telangana, the company manufactures confectionery, éclairs, candies, lollIPOps, toffees, and centre-filled products. Its client base includes large multinational corporations such as Mondelez India Pvt Ltd, Perfetti Van Melle, Reliance, DS Group, and Nestlé. Notably, Sampre has been associated with Mondelez for over 30 years and is the sole manufacturer of éclairs for India, China, and South Africa.
With steady contracts, strong quarterly performance, and planned fundraising, the company is positioning itself for long-term growth in the nutraceutical and food manufacturing segment. Investors in small-cap stocks often track such agreements and fundraising plans for potential multibagger opportunities, especially when supported by consistent quarterly results.
Disclaimer: The article is for informational purposes only and not investment advice.